Skip to content
    Beiersdorf Venture Capital logo

    Beiersdorf Venture Capital

    Hamburg, GermanyFounded 2020

    Beiersdorf Venture Capital (BVC) is the corporate venture capital arm of Beiersdorf AG, the Hamburg-based global skincare company behind brands such as Nivea and Eucerin. Founded in 2020, BVC partners with startups at the intersection of life sciences, biotechnology, sustainability, AI, and digital health to drive innovation in skincare. In 2025, Beiersdorf launched its second-generation €100 million ($115M) Skin Care Innovation Fund, with individual investments typically ranging from €0.5M to €5M per deal.

    Deal activity decreased year-over-year (1 deals in the last 12 months vs 3 prior). Their most common stage is series-a (43% of deals). Average disclosed round size is $69.0M (across 4 rounds with reported amounts).

    Find people at Beiersdorf Venture Capital on Goldilocks AI

    Portfolio

    7

    Fund Size

    $115M

    Top Stage

    Series A

    Last 12 Mo

    1

    Team

    Dr. Gunes Bozkurt

    Dr. Gunes Bozkurt

    Director of Venture Investments & Lead of Life Science Investments

    Chunchun Yao

    Chunchun Yao

    Investment Principal

    Oleg Chervonnyi

    Oleg Chervonnyi

    Investment Principal

    Ascan Voswinckel

    Ascan Voswinckel

    Head of Venture Capital

    Dr. Janina Zippel

    Dr. Janina Zippel

    Senior Scientist R&D Startup Scouting

    Dr. Thomas Raschke

    Dr. Thomas Raschke

    Team Lead R&D Startup Scouting

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    7 investments
    CompanyRoundAmountDate
    Melt&Marble logoMelt&MarbleSeries ADec 2025
    DDePolySeed$23MJan 2025
    DeepLife logoDeepLifeSeries ADec 2024
    Evommune logoEvommuneSeries C$115MOct 2024
    EEVOMMUNE INC.Series C$115MOct 2024
    DePoly logoDePolySeed$23M
    RReVentasSeries A

    Top Co-Investors

    Last updated: 8 September 2026